Log In
BCIQ
Print this Print this
 

ENV1105

  Manage Alerts
Collapse Summary General Information
Company Envisia Therapeutics Inc.
DescriptionIntravitreal, fully biodegradable PRINT particle formulation of the steroid dexamethasone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetic macular edema (DME)
Indication DetailsTreat diabetic macular edema (DME)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today